Logo image of TFFP

TFF Pharmaceuticals Inc (TFFP) Stock Fundamental Analysis

USA - NASDAQ:TFFP - US87241J2033 - Common Stock

0.065 USD
-0.1 (-60.05%)
Last: 12/12/2024, 8:00:00 PM
0.135 USD
+0.07 (+107.69%)
After Hours: 12/12/2024, 8:00:00 PM
Fundamental Rating

3

TFFP gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 192 industry peers in the Pharmaceuticals industry. While TFFP seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, TFFP is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

TFFP had negative earnings in the past year.
In the past year TFFP has reported a negative cash flow from operations.
TFFP had negative earnings in each of the past 5 years.
In the past 5 years TFFP always reported negative operating cash flow.
TFFP Yearly Net Income VS EBIT VS OCF VS FCFTFFP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M

1.2 Ratios

Looking at the Return On Assets, with a value of -261.68%, TFFP is doing worse than 92.67% of the companies in the same industry.
TFFP has a Return On Equity of -590.38%. This is amonst the worse of the industry: TFFP underperforms 81.68% of its industry peers.
Industry RankSector Rank
ROA -261.68%
ROE -590.38%
ROIC N/A
ROA(3y)-128.2%
ROA(5y)-111.66%
ROE(3y)-147.01%
ROE(5y)-124.69%
ROIC(3y)N/A
ROIC(5y)N/A
TFFP Yearly ROA, ROE, ROICTFFP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 1K 2K 3K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for TFFP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TFFP Yearly Profit, Operating, Gross MarginsTFFP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 -10K -20K -30K

More info and screens

5

2. Health

2.1 Basic Checks

TFFP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TFFP has less shares outstanding
The number of shares outstanding for TFFP has been reduced compared to 5 years ago.
There is no outstanding debt for TFFP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TFFP Yearly Shares OutstandingTFFP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
TFFP Yearly Total Debt VS Total AssetsTFFP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -34.71, we must say that TFFP is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -34.71, TFFP is not doing good in the industry: 91.10% of the companies in the same industry are doing better.
There is no outstanding debt for TFFP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -34.71
ROIC/WACCN/A
WACC9.6%
TFFP Yearly LT Debt VS Equity VS FCFTFFP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M

2.3 Liquidity

A Current Ratio of 0.89 indicates that TFFP may have some problems paying its short term obligations.
TFFP has a Current ratio of 0.89. This is amonst the worse of the industry: TFFP underperforms 89.53% of its industry peers.
TFFP has a Quick Ratio of 0.89. This is a bad value and indicates that TFFP is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.89, TFFP is doing worse than 83.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.89
Quick Ratio 0.89
TFFP Yearly Current Assets VS Current LiabilitesTFFP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 50.46% over the past year.
TFFP shows a strong growth in Revenue. In the last year, the Revenue has grown by 25.57%.
EPS 1Y (TTM)50.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64%
Revenue 1Y (TTM)25.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-17.71%

3.2 Future

TFFP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.17% yearly.
TFFP is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 153.49% yearly.
EPS Next Y65.1%
EPS Next 2Y30.1%
EPS Next 3Y21.17%
EPS Next 5YN/A
Revenue Next Year60.13%
Revenue Next 2Y5.41%
Revenue Next 3Y153.49%
Revenue Next 5YN/A

3.3 Evolution

TFFP Yearly Revenue VS EstimatesTFFP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
TFFP Yearly EPS VS EstimatesTFFP Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -10 -20 -30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TFFP. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TFFP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TFFP Price Earnings VS Forward Price EarningsTFFP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TFFP Per share dataTFFP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6

4.3 Compensation for Growth

TFFP's earnings are expected to grow with 21.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.1%
EPS Next 3Y21.17%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TFFP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TFF Pharmaceuticals Inc

NASDAQ:TFFP (12/12/2024, 8:00:00 PM)

After market: 0.135 +0.07 (+107.69%)

0.065

-0.1 (-60.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-20 2024-11-20/amc
Earnings (Next)N/A N/A
Inst Owners22.48%
Inst Owner Change0%
Ins Owners3.36%
Ins Owner Change0%
Market Cap288.60K
Revenue(TTM)1.16M
Net Income(TTM)-18521700
Analysts82.86
Price Target30.6 (46976.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.8%
Min EPS beat(2)1.96%
Max EPS beat(2)29.64%
EPS beat(4)3
Avg EPS beat(4)8.63%
Min EPS beat(4)-4.11%
Max EPS beat(4)29.64%
EPS beat(8)7
Avg EPS beat(8)20.47%
EPS beat(12)9
Avg EPS beat(12)12.21%
EPS beat(16)10
Avg EPS beat(16)4.34%
Revenue beat(2)1
Avg Revenue beat(2)159.82%
Min Revenue beat(2)-5.2%
Max Revenue beat(2)324.84%
Revenue beat(4)3
Avg Revenue beat(4)124.27%
Min Revenue beat(4)-5.2%
Max Revenue beat(4)324.84%
Revenue beat(8)6
Avg Revenue beat(8)325.23%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)22.34%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)166.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.25
P/FCF N/A
P/OCF N/A
P/B 0.09
P/tB 0.09
EV/EBITDA N/A
EPS(TTM)-6.44
EYN/A
EPS(NY)-3.85
Fwd EYN/A
FCF(TTM)-2.85
FCFYN/A
OCF(TTM)-2.84
OCFYN/A
SpS0.26
BVpS0.71
TBVpS0.71
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -261.68%
ROE -590.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-128.2%
ROA(5y)-111.66%
ROE(3y)-147.01%
ROE(5y)-124.69%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.89
Quick Ratio 0.89
Altman-Z -34.71
F-Score4
WACC9.6%
ROIC/WACCN/A
Cap/Depr(3y)402.4%
Cap/Depr(5y)N/A
Cap/Sales(3y)429.86%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64%
EPS Next Y65.1%
EPS Next 2Y30.1%
EPS Next 3Y21.17%
EPS Next 5YN/A
Revenue 1Y (TTM)25.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-17.71%
Revenue Next Year60.13%
Revenue Next 2Y5.41%
Revenue Next 3Y153.49%
Revenue Next 5YN/A
EBIT growth 1Y21.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year209.69%
EBIT Next 3Y45.36%
EBIT Next 5YN/A
FCF growth 1Y60.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y58.76%
OCF growth 3YN/A
OCF growth 5YN/A

TFF Pharmaceuticals Inc / TFFP FAQ

What is the fundamental rating for TFFP stock?

ChartMill assigns a fundamental rating of 3 / 10 to TFFP.


What is the valuation status of TFF Pharmaceuticals Inc (TFFP) stock?

ChartMill assigns a valuation rating of 1 / 10 to TFF Pharmaceuticals Inc (TFFP). This can be considered as Overvalued.


What is the profitability of TFFP stock?

TFF Pharmaceuticals Inc (TFFP) has a profitability rating of 0 / 10.


What is the earnings growth outlook for TFF Pharmaceuticals Inc?

The Earnings per Share (EPS) of TFF Pharmaceuticals Inc (TFFP) is expected to grow by 65.1% in the next year.